Alon Herschhorn

14PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsImmunogenetics (incl. genetic immunology)Innate immunityEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 28, 2026
Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.

|Nov 07, 2025
Highly efficient production of HIV-1AD8 gp120 in mammalian cells.

Tanvi Mathur, Shamim Ahmed, Durgadevi Parthasarathy

|Aug 26, 2024
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies.

Durgadevi Parthasarathy, Karunakar Reddy Pothula, Sneha Ratnapriya

|Jul 17, 2024
mRNA-based HIV-1 vaccines.

Shamim Ahmed, Alon Herschhorn

|Mar 12, 2024
Alternative substitutions of N332 in HIV-1AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan.

Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed

|Mar 01, 2024
HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies.

Milind Misra, Jeffy Jeffy, Charis Liao

Pageof 3

Frequent Collaborators

1 joint publications

Anthony R Braun

1 joint publications

Carolyn N Paulson

1 joint publications

Jonathan N Sachs

1 joint publications

Courtney C Aldrich